Takeda’s Entyvio Approved By FDA for Ulcerative Colitis, Crohn’s Disease

Takeda’s Entyvio Approved By FDA for Ulcerative Colitis, Crohn’s Disease
The Entyvio (vedolizumab) injection to treat adult patients with moderate to severe ulcerative colitis (UC) and Crohn‘s disease (CD) was recently approved by the U.S. Food and Drug Administration. The drug, which was developed by the largest pharmaceutical company in Japan, Takeda Pharmaceuticals, will now be commercially available to American healthcare providers and is recommended when one or more

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *